These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1678894)

  • 1. Effects of cannabidiol in animal models predictive of antipsychotic activity.
    Zuardi AW; Rodrigues JA; Cunha JM
    Psychopharmacology (Berl); 1991; 104(2):260-4. PubMed ID: 1678894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice.
    Sonego AB; Gomes FV; Del Bel EA; Guimaraes FS
    Behav Brain Res; 2016 Aug; 309():22-8. PubMed ID: 27131780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of central stimulating effects between ephedrine and apomorphine].
    Li Q; Li BH
    Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):468-71. PubMed ID: 1819906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
    Wambebe C
    Jpn J Pharmacol; 1987 Feb; 43(2):121-8. PubMed ID: 2883335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
    Lipska BK; Jaskiw GE; Braun AR; Weinberger DR
    Biol Psychiatry; 1995 Aug; 38(4):255-62. PubMed ID: 8547448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
    Pereira M; Siba IP; Chioca LR; Correia D; Vital MA; Pizzolatti MG; Santos AR; Andreatini R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1636-44. PubMed ID: 21689712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
    Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
    Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.
    Owolabi AR; Akanmu MA; Ukponmwan OE
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):117-24. PubMed ID: 18408917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice.
    Gomes FV; Del Bel EA; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():43-7. PubMed ID: 23791616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of the effect of ketamine on some dopaminergic behaviors in rats.
    Morato GS; Takahashi RN
    Braz J Med Biol Res; 1986; 19(3):403-9. PubMed ID: 3594006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice.
    Yurek DM; Randall PK
    Life Sci; 1985 Nov; 37(18):1665-73. PubMed ID: 4058245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
    Bardin L; Kleven MS; Barret-Grévoz C; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1869-79. PubMed ID: 16237379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
    Takahashi S; Sonehara K; Takagi K; Miwa T; Horikomi K; Mita N; Nagase H; Iizuka K; Sakai K
    Psychopharmacology (Berl); 1999 Aug; 145(3):295-302. PubMed ID: 10494578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioning of behavioural effects produced by an intermediate dose of apomorphine: hypokinesia, ptosis and stereotypies.
    Nowak K; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):262-6. PubMed ID: 3683596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.